STRATA CRITICAL MEDICAL, INC. Segment Expenditure Addition To Long Lived Assets
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Segment Expenditure Addition To Long Lived Assets of $4.92 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2025-08-05
- 2025-06-30: Segment Expenditure Addition To Long Lived Assets 6 month $4.92M.
- 2024-06-30: Segment Expenditure Addition To Long Lived Assets 6 month $16.98M.
| Period end | Segment Expenditure Addition To Long Lived Assets 6 month |
|---|---|
| 2025-06-30 | $4.92M 10-Q · filed 2025-08-05 |
| 2024-06-30 | $16.98M 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |